Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Galvão-Filho

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Microbiology|September 23, 2019
Monocyte-derived dendritic cells in malariaIsabella C Hirako, Patrícia A Assis, Bruno Galvão-Filho, et al.
Mucosal Immunology|October 20, 2018
The emergence of pathogenic TNF/iNOS producing dendritic cells (Tip-DCs) in a malaria model of acute respiratory distress syndrome (ARDS) is dependent on CCR4Bruno Galvão-Filho, Júlia Teixeira de Castro, Maria Marta Figueiredo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2011
Trypanosoma cruzi as an effective cancer antigen delivery vectorCaroline Junqueira, Luara I Santos, Bruno Galvão-Filho, et al.
Frontiers in Microbiology|November 28, 2017
Down Modulation of Host Immune Response by Amino Acid Repeats Present in a <i>Trypanosoma cruzi</i> Ribosomal AntigenCarlos A Toro Acevedo, Bruna M Valente, Gabriela A Burle-Caldas, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2014
Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1Luara Isabela Dos Santos, Bruno Galvão-Filho, Paula Cristina de Faria, et al.
Plos One|May 3, 2013
Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionRafael Polidoro Alves Barbosa, Bruno Galvão Filho, Luara Isabela Dos Santos, et al.
Plos One|May 9, 2012
Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccineCaroline Junqueira, Ana Tereza Guerrero, Bruno Galvão-Filho, et al.
Plos One|June 14, 2014
Protective immunity and safety of a genetically modified influenza virus vaccineRafael Polidoro Alves Barbosa, Ana Paula Carneiro Salgado, Cristiana Couto Garcia, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Microbiology|September 23, 2019
Monocyte-derived dendritic cells in malariaIsabella C Hirako, Patrícia A Assis, Bruno Galvão-Filho, et al.
Mucosal Immunology|October 20, 2018
The emergence of pathogenic TNF/iNOS producing dendritic cells (Tip-DCs) in a malaria model of acute respiratory distress syndrome (ARDS) is dependent on CCR4Bruno Galvão-Filho, Júlia Teixeira de Castro, Maria Marta Figueiredo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2011
Trypanosoma cruzi as an effective cancer antigen delivery vectorCaroline Junqueira, Luara I Santos, Bruno Galvão-Filho, et al.
Frontiers in Microbiology|November 28, 2017
Down Modulation of Host Immune Response by Amino Acid Repeats Present in a <i>Trypanosoma cruzi</i> Ribosomal AntigenCarlos A Toro Acevedo, Bruna M Valente, Gabriela A Burle-Caldas, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2014
Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1Luara Isabela Dos Santos, Bruno Galvão-Filho, Paula Cristina de Faria, et al.
Plos One|May 3, 2013
Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionRafael Polidoro Alves Barbosa, Bruno Galvão Filho, Luara Isabela Dos Santos, et al.
Plos One|May 9, 2012
Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccineCaroline Junqueira, Ana Tereza Guerrero, Bruno Galvão-Filho, et al.
Plos One|June 14, 2014
Protective immunity and safety of a genetically modified influenza virus vaccineRafael Polidoro Alves Barbosa, Ana Paula Carneiro Salgado, Cristiana Couto Garcia, et al.
Pageof 1